Physician profile
Regine Dyer
NPI 1114359346
$6,449.57
in general payments reported to CMS, 2019-2025
11 companies · $1,373 in 2025
The $1,373 reported for 2025 was more than what 95% of Endodontics providers received nationally (typical 2025 total: $58.83).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $863 · 2022: $399 · 2023: $3,555 · 2024: $260 · 2025: $1,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,666 · Food and Beverage: $1,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,666.29 |
| Food and Beverage | $1,521.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonendo INC | $4,276.91 | 2023-2025 | Gentlewave G4 Console |
| Midmark Corporation | $769.60 | 2021 | |
| Patterson Companies, INC. | $459.91 | 2021-2025 | |
| A-Dec, INC. | $425.18 | 2023 | |
| Align Technology, INC. | $337.36 | 2021-2025 | Itero Element 5d Plus, Invisalign, Invisalign Go |
| Zimvie INC. | $56.46 | 2022 | |
| Dentsply Sirona INC | $46.74 | 2022-2023 | Astra Tech Implant System |
| Colgate Oral Pharmaceuticals, INC. | $30.58 | 2025 | |
| Envista Holdings Corporation | $22.34 | 2024 | Endodontics |
| 3m Company | $12.91 | 2022 | |
| Ultradent Products INC | $11.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regine Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.